KORU Medical Systems (KRMD) vs Pulmonx (LUNG)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Pulmonx (LUNG) has outperformed KORU Medical Systems (KRMD) over the past year, gaining 6.4% versus a loss of 24.2%. Over five years, KRMD leads with a +3.8% price change compared with -95.4% for LUNG. KORU Medical Systems is the larger company by market cap ($136.9 million vs $79.0 million), about 1.7 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | KRMD | LUNG |
|---|---|---|
| Share price | $2.98 | $1.84 |
| Market cap | $136.88M | $79.02M |
| 1-day change | -0.67% | +3.37% |
| YTD return | -48.71% | -16.74% |
| 1-year return | -24.17% | +6.36% |
| 5-year return | +3.83% | -95.38% |
| Forward P/E | 85.14 | — |
| EPS (TTM) | $-0.04 | $-1.19 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $6.61 | $2.89 |
| 52-week low | $2.86 | $1.13 |
| Distance from 52-week high | -54.90% | -36.33% |
| Analyst consensus | none | — |
| Avg. price target upside | +109.73% | — |
| Average volume | 234.58K | 478.80K |
| Shares outstanding | 45.93M | 42.95M |
| Employees | 73 | — |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- LUNG has outperformed KRMD by 30.5 percentage points over the past year.
About KORU Medical Systems
KRMD stock →KORU Medical Systems, Inc. develops, manufactures, and commercializes subcutaneous infusion solutions primarily for the subcutaneous drug delivery market in the United States and internationally.
Health Care · Medical/Dental Instruments · 73 employees
KRMD vs LUNG FAQ
Which is bigger, KORU Medical Systems or Pulmonx?
KORU Medical Systems (KRMD) is larger, with a market capitalization of $136.88M compared with $79.02M for Pulmonx (LUNG).
Which stock has performed better over the past year, KRMD or LUNG?
LUNG returned +6.36% over the past 12 months, compared with -24.17% for KRMD (price return, excluding dividends). Past performance does not predict future results.
Are KORU Medical Systems and Pulmonx in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.